These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 22948090)

  • 21. Accumulation of class switched IgD-IgM- memory B cells in the cerebrospinal fluid during neuroinflammation.
    Cepok S; von Geldern G; Grummel V; Hochgesand S; Celik H; Hartung H; Hemmer B
    J Neuroimmunol; 2006 Nov; 180(1-2):33-9. PubMed ID: 16952404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunophenotype of peripheral T lymphocytes, NK cells and expression of CD69 activation marker in patients with recurrent spontaneous abortions, during the mid-luteal phase.
    Prado-Drayer A; Teppa J; Sánchez P; Camejo MI
    Am J Reprod Immunol; 2008 Jul; 60(1):66-74. PubMed ID: 18593439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural killer cell phenotype and clinical response to interferon-beta therapy in multiple sclerosis.
    Martínez-Rodríguez JE; López-Botet M; Munteis E; Rio J; Roquer J; Montalban X; Comabella M
    Clin Immunol; 2011 Dec; 141(3):348-56. PubMed ID: 21992960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simple enumerations of peripheral blood natural killer (CD56+ NK) cells, B cells and T cells have no predictive value in IVF treatment outcome.
    Thum MY; Bhaskaran S; Bansal AS; Shehata H; Ford B; Sumar N; Abdalla HI
    Hum Reprod; 2005 May; 20(5):1272-6. PubMed ID: 15829490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detailed analysis of peripheral blood natural killer (NK) cells in women with recurrent miscarriage.
    King K; Smith S; Chapman M; Sacks G
    Hum Reprod; 2010 Jan; 25(1):52-8. PubMed ID: 19819893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The CD6 scavenger receptor is differentially expressed on a CD56 natural killer cell subpopulation and contributes to natural killer-derived cytokine and chemokine secretion.
    Braun M; Müller B; ter Meer D; Raffegerst S; Simm B; Wilde S; Spranger S; Ellwart J; Mosetter B; Umansky L; Lerchl T; Schendel DJ; Falk CS
    J Innate Immun; 2011; 3(4):420-34. PubMed ID: 21178331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distress and expression of natural killer receptors on lymphocytes.
    Lutgendorf SK; Moore MB; Bradley S; Shelton BJ; Lutz CT
    Brain Behav Immun; 2005 May; 19(3):185-94. PubMed ID: 15797305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon-beta-1a treatment increases CD56bright natural killer cells and CD4+CD25+ Foxp3 expression in subjects with multiple sclerosis.
    Vandenbark AA; Huan J; Agotsch M; La Tocha D; Goelz S; Offner H; Lanker S; Bourdette D
    J Neuroimmunol; 2009 Oct; 215(1-2):125-8. PubMed ID: 19758707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction of the peripheral blood CD56(bright) NK lymphocyte subset in FTY720-treated multiple sclerosis patients.
    Johnson TA; Evans BL; Durafourt BA; Blain M; Lapierre Y; Bar-Or A; Antel JP
    J Immunol; 2011 Jul; 187(1):570-9. PubMed ID: 21622858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intermediate-affinity interleukin-2 receptor expression predicts CD56(bright) natural killer cell expansion after daclizumab treatment in the CHOICE study of patients with multiple sclerosis.
    Sheridan JP; Zhang Y; Riester K; Tang MT; Efros L; Shi J; Harris J; Vexler V; Elkins JS
    Mult Scler; 2011 Dec; 17(12):1441-8. PubMed ID: 21807759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitation of T-cell receptor V beta chain expression on lymphocytes from blood, brain, and spinal fluid in patients with multiple sclerosis and other neurological diseases.
    Birnbaum G; van Ness B
    Ann Neurol; 1992 Jul; 32(1):24-30. PubMed ID: 1386501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural killer cell activation in the lung allograft early posttransplantation.
    Meehan AC; Sullivan LC; Mifsud NA; Brooks AG; Snell GI; Kotsimbos TC; Westall GP
    Transplantation; 2010 Mar; 89(6):756-63. PubMed ID: 20019647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An increase in the absolute count of CD56dimCD16+CD69+ NK cells in the peripheral blood is associated with a poorer IVF treatment and pregnancy outcome.
    Thum MY; Bhaskaran S; Abdalla HI; Ford B; Sumar N; Shehata H; Bansal AS
    Hum Reprod; 2004 Oct; 19(10):2395-400. PubMed ID: 15319390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional significance of the activation-associated receptors CD25 and CD69 on human NK-cells and NK-like T-cells.
    Clausen J; Vergeiner B; Enk M; Petzer AL; Gastl G; Gunsilius E
    Immunobiology; 2003; 207(2):85-93. PubMed ID: 12675266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytokine and immune cell profiling in the cerebrospinal fluid of patients with neuro-inflammatory diseases.
    Lepennetier G; Hracsko Z; Unger M; Van Griensven M; Grummel V; Krumbholz M; Berthele A; Hemmer B; Kowarik MC
    J Neuroinflammation; 2019 Nov; 16(1):219. PubMed ID: 31727097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intrathecal effects of daclizumab treatment of multiple sclerosis.
    Bielekova B; Richert N; Herman ML; Ohayon J; Waldmann TA; McFarland H; Martin R; Blevins G
    Neurology; 2011 Nov; 77(21):1877-86. PubMed ID: 22076546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunophenotyping of cerebrospinal fluid cells in multiple sclerosis: in search of biomarkers.
    Alvermann S; Hennig C; Stüve O; Wiendl H; Stangel M
    JAMA Neurol; 2014 Jul; 71(7):905-12. PubMed ID: 24818670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The autoimmune disease-associated transcription factors EOMES and TBX21 are dysregulated in multiple sclerosis and define a molecular subtype of disease.
    Parnell GP; Gatt PN; Krupa M; Nickles D; McKay FC; Schibeci SD; Batten M; Baranzini S; Henderson A; Barnett M; Slee M; Vucic S; Stewart GJ; Booth DR
    Clin Immunol; 2014 Mar; 151(1):16-24. PubMed ID: 24495857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased natural killer cell chemotaxis to CXCL12 in patients with multiple sclerosis.
    Serrano-Pertierra E; Blanco-Gelaz MA; Oliva-Nacarino P; Martínez-Camblor P; Villafani J; López-Larrea C; Cernuda-Morollón E
    J Neuroimmunol; 2015 May; 282():39-44. PubMed ID: 25903727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Soluble CD8 levels in the CSF and serum of patients with multiple sclerosis.
    Maimone D; Reder AT
    Neurology; 1991 Jun; 41(6):851-4. PubMed ID: 1904563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.